1. Establish a unique device identification system and promote its incorporation into electronic health information
2. Promote the development of national and international device registries for selected products
3. Modernize adverse event reporting and analysis
4. Develop and use new methods for evidence generation, synthesis and appraisal
The FDA will host four public meetings this month to garner public feedback.